Khoom Taw Qhia:
Intermediate ntawm Caffezomi yog ib qho nruab nrab rau kev sib txuas ntawm proteasome inhibitor Carfilzomib, uas yog siv los ua cov tshuaj tsom rau kev kho mob ntau yam myeloma. CAS: 247068-81-1 Nr.
Daim ntawv thov:
1. Ib lub tsev tseem ceeb hauv kev sib txuas ntawm cov tshuaj tiv thaiv- qog nqaij hlav.
2. Cov txheej txheem kev txhim kho thiab ua kom tiav- nce hauv kev lag luam kws tshuaj.
3. Kev tshawb fawb tshuaj tshiab thiab kev txhim kho thiab kev hloov kho cov txheej txheem platform.
4. Lub hom phiaj kev kawm thiab kev tshawb fawb.
Ntim:
Ntim raws li tus neeg siv khoom xav tau.
Cia tej yam kev mob:
Khaws nyob rau hauv chav tsev kub, deb ntawm lub teeb thiab nyob rau hauv ib lub thawv kaw.
Chaw thau khoom thiab thauj khoom:
Hiav txwv los yog Cua
Qhov zoo:
1. High chemical stability thiab thermal stability;
2. Kev cai Synthesis;
3. Kev tswj xyuas nruj thiab kev txhawb nqa kev ua raws cai;
4. Kev teb sai thiab kev txhawb nqa.
Cim npe nrov: Tuam Tshoj intermediate ntawm caffezomi, cas: 247068-81-1, c14h25no3, Tuam Tshoj intermediate ntawm caffezomi, cas: 247068-81-1, c14h25no3 manufacturers, lwm tus neeg, Hoobkas